Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Justin Kirion
Observed names:
J Kirion,
J. Kirion,
Justin KIRION,
Kirion, Justin
Institution:
Cemka-Eval (France)
Observed institution:
Cemka-Eval (France)
ORCID:
0009-0008-0729-7667
Observed ORCID:
0009-0008-0729-7667
OpenAlex ID:
A5093565682
Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR)
2024
·
Mathurin Fumery
, Romain Altwegg
, et al.
·
Digestive and Liver Disease
·
7
The socioeconomic impacts of fibrodysplasia ossificans progressiva: evidence from a retrospective case-control study in France
2026
·
Geneviève Baujat
, Stéphane Bouée
, et al.
·
JBMR Plus
·
1
Patient preferences on pen injectors for assisted reproductive technology: a discrete choice experiment in France
2024
·
Noémie Ranisavljevic
, Chadi Yazbeck
, et al.
·
Expert Opinion on Drug Delivery
·
1
P47 Evaluation of Natural Language Processing (NLP) on Electronic Medical Records: A Proof of Concept on Chronic Graft Versus Host Disease (cGVHD) in France
2024
·
S Colas
, V Gilles
, et al.
·
Value in Health
·
1
PDF
EE389 Collective vs Health Insurance Perspective in a French Efficiency Model: A Diversity of Cost Measurement Sources
2023
·
E. Alaoui
, T. Arcelin
, et al.
·
Value in Health
·
1
PDF
Description des patients et de la prise en charge de la maladie chronique du greffon contre l'hôte (cGVHD) en France basée sur le traitement du langage naturel (NLP) à partir des comptes-rendus médicaux électroniques
2026
·
Stéphane BOUÉE
, Sylvain CHANTEPIE
, et al.
·
Journal of Epidemiology and Population Health
EE66 Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions
2025
·
Justine Cortes
, Kenza Bouboualia
, et al.
·
Value in Health
EE819 How Can Discrete Choice Experiment Method Improve Patient Care and Engagement? An Example in the Field of Fertility
2024
·
T Arcelin
, P Marino
, et al.
·
Value in Health
EE233 Alternatives to Bayesian Network Meta-Analysis in Case of Proportional Hazards Invalidity: Review of HAS Cost-Utility Studies Opinions in France
2023
·
J. Kirion
, E. Alaoui
, et al.
·
Value in Health
PDF
EE151 Trade-Off between Comparators Comprehensiveness and Methodological Robustness in Cost-Utility Studies Reviewed By Has in France
2023
·
J. Kirion
, E. Alaoui
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
11
Citation count:
11
H-index:
1
I10-index:
Year
Topic
Type
